What Are the 10 Most Dangerous Drugs in America.

Any list of the ten most dangerous drugs in America depends on how danger is measured. Measured by annual mortality, the list is dominated by opioids and other central nervous system depressants. Measured by social harm, it includes alcohol and tobacco alongside the controlled substances that the legal system regulates most strictly. Measured by addiction liability, stimulants and nicotine appear alongside opioids. The measurement matters for understanding both the public health dimensions of the opioid crisis and the regulatory priorities that the measurement has produced.

This article addresses the drugs most relevant to the regulatory and enforcement environment that healthcare practitioners operate within: those whose prescribing and diversion have generated the most significant law enforcement response and that most frequently appear in the investigations described elsewhere in this series.

Fentanyl and Its Analogs

Illicitly manufactured fentanyl and its chemical analogs are responsible for more overdose deaths in the United States than any other drug or drug category, accounting for the majority of the approximately one hundred thousand overdose deaths recorded annually in recent years. Fentanyl's potency, which is approximately one hundred times that of morphine by weight, means that a quantity insufficient to see with the naked eye can be lethal, and the contamination of the illicit drug supply with fentanyl has produced overdose deaths in individuals who did not intend to consume an opioid.

Pharmaceutical fentanyl, prescribed in transdermal patches, lozenges, and injectable forms for severe pain management and anesthesia, is a Schedule II controlled substance whose prescribing is subject to specific requirements. The diversion of pharmaceutical fentanyl from legitimate prescribing channels, and the criminal manufacturing of illicitly manufactured fentanyl by drug trafficking organizations, represent distinct but connected components of the enforcement challenge.

Oxycodone and Hydrocodone

Oxycodone and hydrocodone, the pharmaceutical opioids at the center of the prescription opioid epidemic, remain among the most diverted and abused drugs in the country despite the significant reduction in their prescribing that has occurred since the epidemic's peak. OxyContin, the extended-release oxycodone formulation marketed by Purdue Pharma, became the signature product of the epidemic and the subject of the most significant pharmaceutical company litigation in American history.

Both oxycodone and hydrocodone are Schedule II controlled substances with recognized therapeutic uses in pain management. Their appearance in opioid fraud prosecutions, which is virtually universal, reflects their centrality to the pill mill model that the DEA's opioid enforcement was designed to address.

Methamphetamine

Methamphetamine is a Schedule II stimulant whose illicit use has resurged significantly in recent years, fueled in part by the availability of inexpensive, high-purity methamphetamine produced by Mexican drug trafficking organizations. The combination of methamphetamine with illicitly manufactured fentanyl, which has become increasingly prevalent in the current drug supply, has produced a category of overdose deaths involving both stimulants and opioids that challenges the naloxone reversal approach that is effective for opioid-only overdoses.

Benzodiazepines

Benzodiazepines, including alprazolam, diazepam, and clonazepam, are Schedule IV controlled substances whose combination with opioids substantially increases the risk of fatal respiratory depression. Their appearance in opioid fraud prosecutions, as the co-prescribed sedative that enhanced the opioids' effects in pill mill operations, makes them a specific focus of prescribing oversight in the current enforcement environment.

Heroin and Illicitly Manufactured Opioids

Heroin, a Schedule I substance with no recognized medical use, was the transition drug for many individuals who developed opioid dependence through pharmaceutical prescriptions and subsequently turned to heroin when prescription opioid access was restricted. The heroin supply has been largely displaced by fentanyl in most markets, though heroin use continues and remains a significant contributor to overdose mortality.

The drugs that have produced the most law enforcement response are not necessarily the drugs that cause the most harm in absolute terms. Alcohol and tobacco cause more total mortality than all illicit drugs combined. The regulatory and legal system's treatment of controlled substances reflects a policy judgment about which harms the law can most effectively address, not a comprehensive ranking of all dangerous substances. That policy judgment shapes the enforcement environment within which healthcare practitioners operate, and understanding its basis helps explain why the enforcement priorities are structured as they are.

Cocaine and Crack Cocaine

Cocaine, a Schedule II stimulant with limited medical application as a topical anesthetic, and crack cocaine, its freebase form, have been subjects of federal enforcement for decades. Their role in the current opioid enforcement environment is limited, though the combination of cocaine with fentanyl in the illicit drug supply has produced overdose deaths in individuals seeking a stimulant rather than an opioid.

MDMA and Synthetic Cannabinoids

MDMA, a Schedule I entactogen, and synthetic cannabinoids, which occupy a more complex scheduling status depending on their specific chemical composition, represent categories of substances that appear in healthcare practitioner investigations less frequently than the opioids and benzodiazepines discussed above. Their inclusion in any list of dangerous drugs reflects their abuse potential and their appearance in emergency department presentations, which create the clinical encounters through which healthcare practitioners sometimes encounter them.